Search
+
    SEARCHED FOR:

    FINANCIAL TARGETS

    BJP criticises Congress president Kharge for controversial Diwali remark

    BJP spokespersons have criticised Congress president Mallikarjun Kharge for referring to Diwali as a 'Khushiyon Ka Eid'. They accused Kharge and Rahul Gandhi of disregarding the significance of Hindu festivals and altering their identities. The criticism emphasizes that Diwali is an essential festival with unique traditions and sanctity. BJP representatives question why Kharge would not reciprocate the sentiment by calling Eid a 'Diwali of joy'.

    BOJ's Ueda sees upside risks to inflation, says price growth may accelerate into early 2027

    Bank of Japan Governor Kazuo Ueda flagged upside risks to inflation, warning that rising energy costs could accelerate price growth into early 2027. He said the central bank was targeting sustainable 2% inflation while monitoring global monetary policy, AI-related market risks and cybersecurity threats to financial stability.

    Samvat 2083 stock picks: 10 ideas from India’s top brokerages for the next Diwali

    Brokerages have identified 10 stocks across banking, defence, hospitality, quick commerce, consumption and manufacturing for Samvat 2083. Kotak Mahindra Bank, Bharat Electronics, Indian Hotels, Adani Ports and Eternal feature among their picks, backed by earnings visibility, strong balance sheets and structural growth opportunities. Their target prices suggest further upside potential.

    Sai Life Sciences shares jump 9%, multibagger stock rallies 19% in 3 days after Q2 results. Why Jefferies hiked target price

    Sai Life Sciences shares hit a fresh 52-week high on Monday after strong Q2 results and bullish brokerage commentary. Jefferies retained its Buy rating and raised its target price to Rs 2,050, citing healthy CRO and CDMO growth, a strengthening pipeline and improved earnings prospects.

    Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%

    Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its target price by 23% to Rs 12,550, citing robust CDMO business expansion, strong EBITDA margins, and a solid GLP peptide pipeline.

    Finolex Cables shares fall 5% after rallying 20% during Muhurat Trading session. More upside ahead?

    Finolex Cables shares fell after a 20% upper-circuit rally during Sunday's Muhurat Trading session, giving back some of the Rs 3,334 crore market-cap gain. The sharp rally followed a strong Q2 performance, with consolidated net profit rising 68% YoY to Rs 273 crore and revenue growing 65% to Rs 2,269 crore.

    The Economic Times
    BACK TO TOP